Cholesterol diet and effect of long-term withdrawal on plaque development and composition in the thoracic aorta of New Zealand White rabbits

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 407-413

  Riedmüller, Karen ^a   Metz, Stephan ^b   Bonaterra, Gabriel A ^a,d   Kelber, Olaf ^c   Weiser, Dieter ^c   Metz, Jürgen ^a   Kinscherf, Ralf ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Steigerwald Arzneimittelwerk GmbH   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Apoptosis; Atherosclerosis; Cholesterol; Macrophages; Plaque regression; Plaque stability; Smooth muscle cells

Indexed keywords

CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL DENSITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; MACROPHAGE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; THORACIC AORTA; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMAL FEED; ANIMALS; AORTA; AORTA, THORACIC; CHOLESTEROL, DIETARY; DISEASE PROGRESSION; MACROPHAGES; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PHOSPHOLIPIDS; PLAQUE, ATHEROSCLEROTIC; RABBITS; TIME FACTORS; TRIGLYCERIDES;

EID: 77953230368     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.009     Document Type: Article

References (38)

1. Corti R., Osende J., Hutter R., et al. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis 2007, 190:106-113.
2. Maranhão R.C., Tavares E.R., Padoveze A.F., et al. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Atherosclerosis 2008, 197:959-966.
3. Prasad K. Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis 2008, 197:34-42.
4. Futterman L.G., Lemberg L. Inflammation in plaque rupture: an active participant or an invited guest?. Am J Crit Care 1998, 7:153-161.
5. Libby P., Schoenbeck U., Mach F., Selwyn A.P., Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998, 104(2A):14S-18S.
6. Kinscherf R., Kamencic H., Deigner H.P., et al. Effect of alterations of blood cholesterol levels on macrophages in the myocardium of New Zealand White rabbits. J Leukocyte Biol 1997, 62:719-725.
7. Kinscherf R., Wagner M., Kamencic H., et al. Characterization of apoptotic macrophages in atheromatous tissue of humans and heritable hyperlipidemic rabbits. Atherosclerosis 1999, 144:33-39.
8. Meurice T., Bauters C., Vallet B., et al. bFGF restores endothelium-dependent responses of hypercholesterolemic rabbit thoracic aorta. Am J Physiol 1997, 272:H613-H617.
9. Folch J., Ascoli I., Lees M., Meath J.A., LeBaron F.N. Preparation of lipid extracts from brain tissue. J Biol Chem 1951, 191:833-840.
10. Kinscherf R., Claus R., Wagner M., et al. Apoptosis caused by oxidized-LDL is manganese superoxide dismutase and p53-dependent. FASEB J 1998, 12:461-467.
11. Schlittenhardt D., Schmiedt W., Bonaterra G.A., Metz J., Kinscherf R. Colocalization of oxidized low-density lipoprotein, caspase-3, cyclooxygenase-2, and macrophage migration inhibitory factor in atherosclerotic human carotid arteries. Cell Tissue Res 2005, 322:425-435.
12. Pavlov P., Dickhaus H., Metz J. Quantification of vessel wall changes in stenotic vessels with computer-assisted image processing methods. Biomed Tech (Berlin) 1990, 35(Suppl. 3):288-289.
13. Steiner A., Kendall F.E., Mathers J.A. The abnormal serum lipid pattern in patients with coronary arteriosclerosis. Circulation 1952, 5(4):605-608.
14. Kitchens R.L., Thompson P.A., Munford R.S., O'Keefe G.E. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003, 44:2339-2348.
15. Fournier N., de la Llera Moya M., Burkey B.F., et al. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res 1996, 37(8):1704-1711.
16. Jian B., de la Llera-Moya M., Royer L., et al. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J Lipid Res 1997, 38:734-744.
17. St Clair R.W. Atherosclerosis regression in animal models: current concepts of cellular and biochemical mechanisms. Prog Cardiovasc Dis 1983, 26(2):109-132.
18. Worth N.F., Berry C.L., Thomas A.C., Campbell J.H. S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits. Atherosclerosis 2005, 183:65-73.
19. Chen Y.L., Chang Y.J., Jiang M.J. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits. Atherosclerosis 1999, 143:115-123.
20. Daugherty A., Rateri D.L., Lu H. As Macrophages indulge, atherosclerotic lesions bulge. Circ Res 2008, 102:1445.
21. Kockx M.M., Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovasc Res 2000, 45:736-746.
22. Thorp E., Li Y., Bao L., et al. Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe-/- mice lacking macrophage Bcl-2. Arterioscler Thromb Vasc Biol 2009, 29:169-172.
23. Kolodgie F.D., Narula J., Burke A.P., et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 2000, 157:1259-1268.
24. Heinle H., Brehme U., Friedemann G., et al. Intimal plaque development and oxidative stress in cholesterol-induced atherosclerosis in New Zealand rabbits. Acta Physiol Scand 2002, 176:101-107.
25. Bonaterra G.A., Hildebrandt W., Bodens A., et al. Increased gene expression of scavenger receptors and proinflammatory markers in peripheral blood mononuclear cells of hyperlipidemic males. J Mol Med 2007, 85:181-190.
26. Bennett R. The atherosclerotic plaque was not built in a day: the dynamic nature of plaque progression and instability. Heart Metab 2007, 36:5-7.
27. Libby P., Geng Y.J., Aikawa M., et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996, 7:330-335.
28. Barth J.D. Lipoproteins and the progression/regression of atherosclerosis. Baillieres Clin Endocrinol Metab 1995, 9:849-866.
29. Feyter de P.J., Vos J., Deckers J.W. Progression and regression of the atherosclerotic plaque. Eur Heart J 1995, 16(Suppl. I):26-30.
30. Gijbels M.J., van der Cammen M., van der Laan L.J., et al. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study. Atherosclerosis 1999, 143:15-25.
31. Brown G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990, 323:1289-1298.
32. Hegyi L., Hockings P.D., Benson M.G., et al. Short term arterial remodelling in the aortae of cholesterol fed New Zealand white rabbits shown in vivo by high-resolution magnetic resonance imaging - implications for human pathology. Pathol Oncol Res 2004, 10:159-165.
33. Watanabe T., Hirata M., Yoshikawa Y., et al. Role of macrophages in atherosclerosis. Lab Invest 1985, 53:80-92.
34. Daoud A.S., Fritz K.E., Jarmolych J., Frank A.S. Role of macrophages in regression of atherosclerosis. Ann N Y Acad Sci 1985, 454:101-114.
35. Richardson P.D., Davies M.J., Born G.V.R. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaque. Lancet 1989, 2:941-944.
36. Björkerud S., Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996, 149(2):367-380.
37. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
38. Weissberg P.L., Clesham G.J., Bennett M.R. Is vascular smooth muscle cell proliferation beneficial?. Lancet 1996, 347:305-307.